THE NEW POSSIBILITY FOR BODY REGULATION?

Researchers are excitedly examining retatrutide, a promising drug developed by Eli Lilly, as a possible advance in physique management. Unlike many existing approaches, retatrutide is a dual -action compound targeting equally GLP-1 and GIP, hormones that affect hunger and blood sugar control . Pr